[1]
Z. Chen, “Financial Analysis and Valuation Study of Chinese Listed Companies: The Case of ‘Tongce’ Medical”, JEFAS, vol. 4, no. 2, pp. 324–331, May 2022, doi: 10.32996/jefas.2022.4.2.25.